Cargando…
De Novo Development of Mitochondria-Targeted Molecular Probes Targeting Pink1
Mitochondria play central roles in maintaining cellular metabolic homeostasis, cell survival and cell death, and generate most of the cell’s energy. Mitochondria maintain their homeostasis by dynamic (fission and fusion) and quality control mechanisms, including mitophagy, the removal of damaged mit...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181014/ https://www.ncbi.nlm.nih.gov/pubmed/35682755 http://dx.doi.org/10.3390/ijms23116076 |
_version_ | 1784723662882996224 |
---|---|
author | Ben-Uliel, Shulamit Fluss Zoabi, Faten Habrat Slavin, Moriya Sibony-Benyamini, Hadas Kalisman, Nir Qvit, Nir |
author_facet | Ben-Uliel, Shulamit Fluss Zoabi, Faten Habrat Slavin, Moriya Sibony-Benyamini, Hadas Kalisman, Nir Qvit, Nir |
author_sort | Ben-Uliel, Shulamit Fluss |
collection | PubMed |
description | Mitochondria play central roles in maintaining cellular metabolic homeostasis, cell survival and cell death, and generate most of the cell’s energy. Mitochondria maintain their homeostasis by dynamic (fission and fusion) and quality control mechanisms, including mitophagy, the removal of damaged mitochondria that is mediated mainly by the Pink1/Parkin pathway. Pink1 is a serine/threonine kinase which regulates mitochondrial function, hitherto many molecular mechanisms underlying Pink1 activity in mitochondrial homeostasis and cell fate remain unknown. Peptides are vital biological mediators that demonstrate remarkable potency, selectivity, and low toxicity, yet they have two major limitations, low oral bioavailability and poor stability. Herein, we rationally designed a linear peptide that targets Pink1 and, using straightforward chemistry, we developed molecular probes with drug-like properties to further characterize Pink1. Initially, we conjugated a cell-penetrating peptide and a cross-linker to map Pink1’s 3D structure and its interaction sites. Next, we conjugated a fluorescent dye for cell-imaging. Finally, we developed cyclic peptides with improved stability and binding affinity. Overall, we present a facile approach to converting a non-permeable linear peptide into a research tool possessing important properties for therapeutics. This is a general approach using straightforward chemistry that can be tailored for various applications by numerous laboratories. |
format | Online Article Text |
id | pubmed-9181014 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91810142022-06-10 De Novo Development of Mitochondria-Targeted Molecular Probes Targeting Pink1 Ben-Uliel, Shulamit Fluss Zoabi, Faten Habrat Slavin, Moriya Sibony-Benyamini, Hadas Kalisman, Nir Qvit, Nir Int J Mol Sci Article Mitochondria play central roles in maintaining cellular metabolic homeostasis, cell survival and cell death, and generate most of the cell’s energy. Mitochondria maintain their homeostasis by dynamic (fission and fusion) and quality control mechanisms, including mitophagy, the removal of damaged mitochondria that is mediated mainly by the Pink1/Parkin pathway. Pink1 is a serine/threonine kinase which regulates mitochondrial function, hitherto many molecular mechanisms underlying Pink1 activity in mitochondrial homeostasis and cell fate remain unknown. Peptides are vital biological mediators that demonstrate remarkable potency, selectivity, and low toxicity, yet they have two major limitations, low oral bioavailability and poor stability. Herein, we rationally designed a linear peptide that targets Pink1 and, using straightforward chemistry, we developed molecular probes with drug-like properties to further characterize Pink1. Initially, we conjugated a cell-penetrating peptide and a cross-linker to map Pink1’s 3D structure and its interaction sites. Next, we conjugated a fluorescent dye for cell-imaging. Finally, we developed cyclic peptides with improved stability and binding affinity. Overall, we present a facile approach to converting a non-permeable linear peptide into a research tool possessing important properties for therapeutics. This is a general approach using straightforward chemistry that can be tailored for various applications by numerous laboratories. MDPI 2022-05-28 /pmc/articles/PMC9181014/ /pubmed/35682755 http://dx.doi.org/10.3390/ijms23116076 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ben-Uliel, Shulamit Fluss Zoabi, Faten Habrat Slavin, Moriya Sibony-Benyamini, Hadas Kalisman, Nir Qvit, Nir De Novo Development of Mitochondria-Targeted Molecular Probes Targeting Pink1 |
title | De Novo Development of Mitochondria-Targeted Molecular Probes Targeting Pink1 |
title_full | De Novo Development of Mitochondria-Targeted Molecular Probes Targeting Pink1 |
title_fullStr | De Novo Development of Mitochondria-Targeted Molecular Probes Targeting Pink1 |
title_full_unstemmed | De Novo Development of Mitochondria-Targeted Molecular Probes Targeting Pink1 |
title_short | De Novo Development of Mitochondria-Targeted Molecular Probes Targeting Pink1 |
title_sort | de novo development of mitochondria-targeted molecular probes targeting pink1 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181014/ https://www.ncbi.nlm.nih.gov/pubmed/35682755 http://dx.doi.org/10.3390/ijms23116076 |
work_keys_str_mv | AT benulielshulamitfluss denovodevelopmentofmitochondriatargetedmolecularprobestargetingpink1 AT zoabifatenhabrat denovodevelopmentofmitochondriatargetedmolecularprobestargetingpink1 AT slavinmoriya denovodevelopmentofmitochondriatargetedmolecularprobestargetingpink1 AT sibonybenyaminihadas denovodevelopmentofmitochondriatargetedmolecularprobestargetingpink1 AT kalismannir denovodevelopmentofmitochondriatargetedmolecularprobestargetingpink1 AT qvitnir denovodevelopmentofmitochondriatargetedmolecularprobestargetingpink1 |